Moneycontrol PRO

business

Regulator's generic-drug emphasis surprises pharma biz

CNBC-TV18's Archana Shukla reports that the pharma industry is divided on whether the DCGI order is part of the government's drive to push generics and phase-out brand names.

first published: Oct 18, 2012 10:05 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347